Singapore markets closed

Straits Times Index
3,303.19
+10.26(+0.31%)
S&P 500
5,127.79
+63.59(+1.26%)
Dow
38,675.68
+449.98(+1.18%)
Nasdaq
16,156.33
+315.33(+1.99%)
Bitcoin USD
65,241.97
+1,539.17(+2.42%)
CMC Crypto 200
1,405.69
+93.07(+7.09%)

Valbiotis SA (ALVAL.PA)

Paris - Paris Delayed price. Currency in EUR

Add to watchlist

4.4500

+0.3200

(+7.77%)

As of 11:48AM CEST. Market open.

Loading interactive chart…

Business Wire
Valbiotis Announces the Large Success of the REVERSE-IT International Multicentric Phase II/III Clinical Study on TOTUM•63: Proven Efficacy on the Main Risk Factor of Developing Type 2 Diabetes
LA ROCHELLE, France, May 22, 2023--Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA/PME eligible) (Paris:ALVAL), a commercially oriented Research and Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases, announces the large success of the REVERSE-IT Phase II/III clinical study on TOTUM•63. Conducted in 636 prediabetic and untreated type 2 diabetic patients (early stage), this international, multicentric, randomized and pla